During the past decade, Hospital Teresa Herrera conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Teresa Herrera" #1 sponsor was "Pfizer" with 5 trials, followed by "ETOP IBCSG Partners Foundation" with 4 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Odonate Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Teresa Herrera" #1 collaborator was "Merck Sharp & Dohme LLC" with 6 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator and "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Teresa Herrera" are "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Hemophilia A" (2 trials), "Non-Small Cell Lung Cancer" (2 trials) and "Non-small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Hospital Teresa Herrera" in a lesser frequency.

Most popular intervention types in "Hospital Teresa Herrera" are "Drug" (25 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Pembrolizumab" (5 trials), "Carboplatin" (3 trials), "Gemcitabine" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Teresa Herrera" are 26 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Teresa Herrera". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Teresa Herrera, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Teresa Herrera, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".